
Healthcare · BSE
Incorporated in 1985, Modern Diagnostic & Research Centre Limited is an India-based diagnostic service provider offering a wide range of pathology and radiology services to patients and institutions. The company delivers reliable diagnostic testing along with home sample collection, online report access, and customized health packages designed to meet individual and institutional requirements. It operates 21 centres, including 17 laboratories and 4 diagnostic centres, spread across 8 states, and provides services such as ultrasound, CT scan, MRI, X-ray, ECG, PFT, and specialized diagnostic facilities for cardiac and neurological care. Its pathology services cover routine tests as well as advanced molecular diagnostics, cytogenetics, and specialized testing for genetic disorders and cancer, while radiology services include MRI, CT scans, ultrasound, and digital X-rays using modern equipment. As of February 28, 2025, the company has a workforce of 570 employees, including doctors and consultants.
Price Band
₹85 – ₹90
Issue Size
₹37.00 Cr
Lot Size
1600 shares
GMP
+16.7%
Est. Listing
₹105
at current GMP
Subscribed
376.97x
overall
Open
31 Dec 2025
Close
2 Jan 2026
Allotment
5 Jan 2026
Refund
6 Jan 2026
Demat Credit
7 Jan 2026
Listing
7 Jan 2026
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹90
Band: ₹85 – ₹90
Estimated Listing Price
₹105
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,44,000
Estimated Profit / Lot
₹24,000
1600 × ₹15
Grey Market Premium trend
+₹15
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹15 | 16.7% | ₹105 |
| 30 Oct 2026 | +₹15 | 16.7% | ₹105 |
| 29 Oct 2026 | +₹14 | 15.0% | ₹104 |
GMP is unofficial market data. Not a guarantee of listing performance.
Modern Diagnostic & Research Centre Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹37 Crores. The shares are offered at a price band of ₹85 to ₹90 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,44,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-01-07, while un-allotted funds or UPI block mandates will be released on 2026-01-06.
The latest grey market premium for Modern Diagnostic & Research Centre Limited IPO is ₹15, which indicates an expected listing price of ₹105.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.